Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer

Future Oncol. 2017 May;13(11):947-950. doi: 10.2217/fon-2017-0047.

Authors

Suliman Boulos¹, Danish Mazhar¹, Anne Y Warren², Han Hsi Wong¹

Affiliations

¹ Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0QQ, UK.
² Department of Pathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0QQ, UK.

PMID: 28481147
DOI: 10.2217/fon-2017-0047

No abstract available

Keywords: follow-up; recurrence; testicular cancer.

Publication types

Editorial

MeSH terms

Bleomycin / therapeutic use
Chemotherapy, Adjuvant*
Cisplatin / therapeutic use
Etoposide / therapeutic use
Humans
Male
Neoplasm Recurrence, Local
Neoplasm Staging
Neoplasms, Germ Cell and Embryonal / drug therapy*
Neoplasms, Germ Cell and Embryonal / epidemiology
Neoplasms, Germ Cell and Embryonal / pathology
Testicular Neoplasms / drug therapy*
Testicular Neoplasms / epidemiology
Testicular Neoplasms / pathology

Substances

Bleomycin
Etoposide
Cisplatin

Supplementary concepts

Testicular Germ Cell Tumor